Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.
Lin HK, Uricoli B, Freeman R, Hossian AN, He Z, Anderson JYL, Neffling M, Legier JM, Blake DA, Doxie DB, Nair R, Koff JL, Dhodapkar KM, Shanmugam M, Dreaden EC, Rafiq S.
Lin HK, et al.
Adv Healthc Mater. 2024 Jan 21:e2302425. doi: 10.1002/adhm.202302425. Online ahead of print.
Adv Healthc Mater. 2024.
PMID: 38245855